The most recent insider trading activity occurred on March 20, 2026, with Non-Executive Directors Rosemary Rhoda Budge and Duncan William Allan Budge making purchases. These transactions, along with earlier buys in February 2026 and October 2024, indicate consistent buying interest from directors.